Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patientsCarmen P Escalante, Christina Meyers, James M Reuben, et al.
Plos One|September 25, 2018
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer CenterTamer M Fouad, Naoto T Ueno, Robert K Yu, et al.
Molecular Cancer Therapeutics|September 14, 2012
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancerAntonio Giordano, Hui Gao, Simone Anfossi, et al.
Cancer|March 27, 2018
Development of CNS metastases and survival in patients with inflammatory breast cancerMarc I Uemura, John T French, Kenneth R Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumorsRashmi S Goswami, Keyur P Patel, Rajesh R Singh, et al.
Breast Cancer Research and Treatment|May 5, 2019
Elevated serum levels of sialyl Lewis X (sLe<sup>X</sup>) and inflammatory mediators in patients with breast cancerEvan N Cohen, Tamer M Fouad, Bang-Ning Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypesH Masuda, T M Brewer, D D Liu, et al.
Targeted Oncology|October 22, 2020
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyJulie G Fisher, David Tait, Elizabeth Garrett-Mayer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patientsK Allenson, J Castillo, F A San Lucas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Pageof 29